A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain.
Katz, Nathaniel
A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. [electronic resource] - Current medical research and opinion Jan 2007 - 117-28 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1473-4877
10.1185/030079906x162692 doi
Analgesics, Opioid--administration & dosage
Analysis of Variance
Delayed-Action Preparations
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Low Back Pain--drug therapy
Male
Middle Aged
Oxymorphone--administration & dosage
Pain Measurement
Statistics, Nonparametric
Treatment Outcome
United States
A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. [electronic resource] - Current medical research and opinion Jan 2007 - 117-28 p. digital
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1473-4877
10.1185/030079906x162692 doi
Analgesics, Opioid--administration & dosage
Analysis of Variance
Delayed-Action Preparations
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Low Back Pain--drug therapy
Male
Middle Aged
Oxymorphone--administration & dosage
Pain Measurement
Statistics, Nonparametric
Treatment Outcome
United States